211 related articles for article (PubMed ID: 29973863)
1. Imbalanced Expression of Tau and Tubulin Induces Neuronal Dysfunction in
Miyasaka T; Shinzaki Y; Yoshimura S; Yoshina S; Kage-Nakadai E; Mitani S; Ihara Y
Front Neurosci; 2018; 12():415. PubMed ID: 29973863
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of microtubule assembly competent tubulin synthesis leads to accumulation of phosphorylated tau in neuronal cell bodies.
Fujiwara H; Watanabe S; Iwata M; Ueda S; Nobuhara M; Wada-Kakuda S; Misonou H; Miyasaka T
Biochem Biophys Res Commun; 2020 Jan; 521(3):779-785. PubMed ID: 31699369
[TBL] [Abstract][Full Text] [Related]
3. Distinct Poly(A) nucleases have differential impact on sut-2 dependent tauopathy phenotypes.
Kow RL; Strovas TJ; McMillan PJ; Jacobi AM; Behlke MA; Saxton AD; Latimer CS; Keene CD; Kraemer BC
Neurobiol Dis; 2021 Jan; 147():105148. PubMed ID: 33184027
[TBL] [Abstract][Full Text] [Related]
4. Curcumin improves tau-induced neuronal dysfunction of nematodes.
Miyasaka T; Xie C; Yoshimura S; Shinzaki Y; Yoshina S; Kage-Nakadai E; Mitani S; Ihara Y
Neurobiol Aging; 2016 Mar; 39():69-81. PubMed ID: 26923403
[TBL] [Abstract][Full Text] [Related]
5. SPOP loss of function protects against tauopathy.
Eck RJ; Kow RL; Black AH; Liachko NF; Kraemer BC
Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2207250120. PubMed ID: 36574656
[TBL] [Abstract][Full Text] [Related]
6. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
[TBL] [Abstract][Full Text] [Related]
7. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
[TBL] [Abstract][Full Text] [Related]
8. Activated cofilin exacerbates tau pathology by impairing tau-mediated microtubule dynamics.
Woo JA; Liu T; Fang CC; Cazzaro S; Kee T; LePochat P; Yrigoin K; Penn C; Zhao X; Wang X; Liggett SB; Kang DE
Commun Biol; 2019; 2():112. PubMed ID: 30911686
[TBL] [Abstract][Full Text] [Related]
9. MSUT2 is a determinant of susceptibility to tau neurotoxicity.
Guthrie CR; Greenup L; Leverenz JB; Kraemer BC
Hum Mol Genet; 2011 May; 20(10):1989-99. PubMed ID: 21355046
[TBL] [Abstract][Full Text] [Related]
10. Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model.
Guha S; Fischer S; Johnson GVW; Nehrke K
Mol Neurodegener; 2020 Nov; 15(1):65. PubMed ID: 33168053
[TBL] [Abstract][Full Text] [Related]
11. Seizures are a druggable mechanistic link between TBI and subsequent tauopathy.
Alyenbaawi H; Kanyo R; Locskai LF; Kamali-Jamil R; DuVal MG; Bai Q; Wille H; Burton EA; Allison WT
Elife; 2021 Feb; 10():. PubMed ID: 33527898
[TBL] [Abstract][Full Text] [Related]
12. The homologous carboxyl-terminal domains of microtubule-associated protein 2 and TAU induce neuronal dysfunction and have differential fates in the evolution of neurofibrillary tangles.
Xie C; Miyasaka T; Yoshimura S; Hatsuta H; Yoshina S; Kage-Nakadai E; Mitani S; Murayama S; Ihara Y
PLoS One; 2014; 9(2):e89796. PubMed ID: 24587039
[TBL] [Abstract][Full Text] [Related]
13. Alteration of mitochondrial homeostasis is an early event in a
Palikaras K; Achanta K; Choi S; Akbari M; Bohr VA
Aging (Albany NY); 2021 Nov; 13(21):23876-23894. PubMed ID: 34751671
[TBL] [Abstract][Full Text] [Related]
14. DOPA Decarboxylase Modulates Tau Toxicity.
Kow RL; Sikkema C; Wheeler JM; Wilkinson CW; Kraemer BC
Biol Psychiatry; 2018 Mar; 83(5):438-446. PubMed ID: 28751068
[TBL] [Abstract][Full Text] [Related]
15. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
16. Tau-Driven Neuronal and Neurotrophic Dysfunction in a Mouse Model of Early Tauopathy.
Mazzaro N; Barini E; Spillantini MG; Goedert M; Medini P; Gasparini L
J Neurosci; 2016 Feb; 36(7):2086-100. PubMed ID: 26888921
[TBL] [Abstract][Full Text] [Related]
17. Increased neuronal activity in motor cortex reveals prominent calcium dyshomeostasis in tauopathy mice.
Wu Q; Bai Y; Li W; Congdon EE; Liu W; Lin Y; Ji C; Gan WB; Sigurdsson EM
Neurobiol Dis; 2021 Jan; 147():105165. PubMed ID: 33166699
[TBL] [Abstract][Full Text] [Related]
18. Human Tau Aggregates Are Permissive to Protein Synthesis-Dependent Memory in
Vourkou E; Rouiz Ortega ED; Mahajan S; Mudher A; Skoulakis EMC
J Neurosci; 2023 Apr; 43(16):2988-3006. PubMed ID: 36868851
[TBL] [Abstract][Full Text] [Related]
19. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
20. Positron Emission Tomography in Animal Models of Tauopathies.
Cao L; Kong Y; Ji B; Ren Y; Guan Y; Ni R
Front Aging Neurosci; 2021; 13():761913. PubMed ID: 35082657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
